{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T04:21:27Z","timestamp":1768623687300,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Recent international guidelines for acute pancreatitis (AP) recommend limiting anti-infective therapy (AIT) to cases of suspected necrotizing AP or nosocomial extrapancreatic infection. Limited data are available concerning empirical and documented AIT prescribing practices in patients admitted to the intensive care unit (ICU) for the management of AP.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Using a multicentre, retrospective (2009\u20132014), observational database of ICU patients admitted for AP, our primary objective was to assess the incidence of AIT prescribing practices during the first 30\u2009days following admission. Secondary objectives were to assess the independent impact of centre characteristics on the incidence of AIT and to identify factors associated with crude hospital mortality in a logistic regression model.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In this cohort of 860 patients, 359 (42%) received AIT on admission. Before day 30, 340\/359 (95%) AIT patients and 226\/501 (45%) AIT-free patients on admission received additional AIT, mainly for intra-abdominal and lung infections. A large heterogeneity was observed between centres in terms of the incidence of infections, therapeutic management including AIT and prognosis. Administration of AIT on admission or until day 30 was not associated with an increased mortality rate. Patients receiving AIT on admission had increased rates of complications (septic shock, intra-abdominal and pulmonary infections), therapeutic (surgical, percutaneous, endoscopic) interventions and increased length of ICU stay compared to AIT-free patients. Patients receiving delayed AIT after admission and until day 30 had increased rates of complications (respiratory distress syndrome, intra-abdominal and pulmonary infections), therapeutic interventions and increased length of ICU stay compared to those receiving AIT on admission. Risk factors for hospital mortality assessed on admission were age (adjusted odds ratio [95% confidence interval] 1.03 [1.02\u20131.05]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), Balthazar score E (2.26 [1.43\u20133.56]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), oliguria\/anuria (2.18 [1.82\u20134.33]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), vasoactive support (2.83 [1.73\u20134.62]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and mechanical ventilation (1.90 [1.15\u20133.14]; <jats:italic>p<\/jats:italic>\u2009=\u20090.011), but not AIT (0.63 [0.40\u20131.01]; <jats:italic>p<\/jats:italic>\u2009=\u20090.057).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>High proportions of ICU patients admitted for AP receive AIT, both on admission and during their ICU stay. A large heterogeneity was observed between centres in terms of incidence of infections, AIT prescribing practices, therapeutic management and outcome. AIT reflects the initial severity and complications of AP, but is not a risk factor for death.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13054-019-2681-5","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T17:17:04Z","timestamp":1575566224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-5705","authenticated-orcid":false,"given":"Philippe","family":"Montravers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Lefrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lescot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Nesseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Paugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Jabaudon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"4 Suppl 2","key":"2681_CR1","first-page":"e1","volume":"13","author":"Working Group IAP\/APA Acute Pancreatitis Guidelines","year":"2013","unstructured":"Working Group IAP\/APA Acute Pancreatitis Guidelines. IAP\/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1\u201315.","journal-title":"Pancreatology."},{"key":"2681_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1053\/j.gastro.2018.01.032","volume":"154","author":"SD Crockett","year":"2018","unstructured":"Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154:1096\u2013101.","journal-title":"Gastroenterology."},{"issue":"6","key":"2681_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.pan.2016.08.012","volume":"16","author":"Minas Baltatzis","year":"2016","unstructured":"Baltatzis M, Mason JM, Chandrabalan V, Stathakis P, McIntyre B, Jegatheeswaran S, et al. Antibiotic use in acute pancreatitis: an audit of current practice in a tertiary Centre. Pancreatology. 2016;16:946\u201351.","journal-title":"Pancreatology"},{"key":"2681_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archsurg.139.12.1371","volume":"139","author":"JJ De Waele","year":"2004","unstructured":"De Waele JJ, Vogelaers D, Hoste E, Blot S, Colardyn F. Emergence of antibiotic resistance in infected pancreatic necrosis. Arch Surg. 2004;139:1371\u20135.","journal-title":"Arch Surg"},{"issue":"10","key":"2681_CR5","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1038\/s41424-018-0056-x","volume":"9","author":"Saransh Jain","year":"2018","unstructured":"Jain S, Mahapatra SJ, Gupta S, Shalimar, Garg PK Infected pancreatic necrosis due to multidrug-resistant organisms and persistent organ failure predict mortality in acute pancreatitis Clin Transl Gastroenterol 2018;9:190.","journal-title":"Clinical and Translational Gastroenterology"},{"key":"2681_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/gastro\/goy005","volume":"6","author":"D Kothari","year":"2018","unstructured":"Kothari D, Struyvenberg MR, Perillo MC, Ezaz G, Freedman SD, Sheth SG. Extra-pancreatic complications, especially hemodialysis predict mortality and length of stay, in ICU patients admitted with acute pancreatitis. Gastroenterol Rep. 2018;6:202\u20139.","journal-title":"Gastroenterol Rep"},{"key":"2681_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MPA.0000000000001019","volume":"47","author":"P Moka","year":"2018","unstructured":"Moka P, Goswami P, Kapil A, Xess I, Sreenivas V, Saraya A. Impact of antibiotic-resistant bacterial and fungal infections in outcome of acute pancreatitis. Pancreas. 2018;47:489\u201394.","journal-title":"Pancreas."},{"key":"2681_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.pan.2018.05.481","volume":"18","author":"E Pando","year":"2018","unstructured":"Pando E, Alberti P, Hidalgo J, Vidal L, Dopazo C, Caralt M, et al. The role of extra-pancreatic infections in the prediction of severity and local complications in acute pancreatitis. Pancreatology. 2018;18:486\u201393.","journal-title":"Pancreatology."},{"key":"2681_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1089\/sur.2012.228","volume":"15","author":"JJ De Waele","year":"2014","unstructured":"De Waele JJ, Rello J, Anzueto A, Moreno R, Lipman J, Sakr Y, et al. Infections and use of antibiotics in patients admitted for severe acute pancreatitis: data from the EPIC II study. Surg Infect. 2014;15:394\u20138.","journal-title":"Surg Infect"},{"key":"2681_CR10","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1097\/CCM.0000000000002874","volume":"46","author":"M Jabaudon","year":"2018","unstructured":"Jabaudon M, Belhadj-Tahar N, Rimmele T, Joannes-Boyau O, Bulyez S, Lefrant JY, et al. Thoracic epidural analgesia and mortality in acute pancreatitis: a multicenter propensity analysis. Crit Care Med. 2018;46:e198\u2013205.","journal-title":"Crit Care Med"},{"key":"2681_CR11","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"ML Levy","year":"2003","unstructured":"Levy ML, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250\u20136.","journal-title":"Crit Care Med"},{"key":"2681_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"2681_CR13","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1136\/gut.2008.152702","volume":"57","author":"BU Wu","year":"2008","unstructured":"Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57:1698\u2013703.","journal-title":"Gut."},{"key":"2681_CR14","volume-title":"Antibioth\u00e9rapie probabiliste des \u00e9tats septiques graves. Conf\u00e9rence d\u2019experts","author":"Societ\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie-R\u00e9animation","year":"2004","unstructured":"Societ\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie-R\u00e9animation. Antibioth\u00e9rapie probabiliste des \u00e9tats septiques graves. Conf\u00e9rence d\u2019experts. Paris: Elsevier; 2004."},{"key":"2681_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580\u2013637.","journal-title":"Crit Care Med"},{"key":"2681_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12664-014-0494-7","volume":"33","author":"R Talukdar","year":"2014","unstructured":"Talukdar R, Ingale P, Choudhury HP, Dhingra R, Shetty S, Joshi H, et al. Antibiotic use in acute pancreatitis: an Indian multicenter observational study. Indian J Gastroenterol. 2014;33:458\u201365.","journal-title":"Indian J Gastroenterol"},{"key":"2681_CR17","unstructured":"Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de Gastroent\u00e9rologie. Consensus conference: acute pancreatitis. Gastroenterol Clin Biol 2001;25:177\u2013192."},{"key":"2681_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/01.sla.0000250414.09255.84","volume":"245","author":"EP Dellinger","year":"2007","unstructured":"Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245:674\u201383.","journal-title":"Ann Surg"},{"key":"2681_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/j.gastro.2003.12.050","volume":"126","author":"R Isenmann","year":"2004","unstructured":"Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997\u20131004.","journal-title":"Gastroenterology."},{"key":"2681_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1572-0241.2007.01575.x","volume":"103","author":"Y Bai","year":"2008","unstructured":"Bai Y, Gao J, Zou DW, Li ZS. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103:104\u201310.","journal-title":"Am J Gastroenterol"},{"key":"2681_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/bjs.5389","volume":"93","author":"T Mazaki","year":"2006","unstructured":"Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg. 2006;93:674\u201384.","journal-title":"Br J Surg"},{"key":"2681_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.pan.2018.05.485","volume":"18","author":"J Barrie","year":"2018","unstructured":"Barrie J, Jamdar S, Smith N, McPherson SJ, Siriwardena AK, O'Reilly DA. Mis-use of antibiotics in acute pancreatitis: insights from the United Kingdom\u2019s National Confidential Enquiry into patient outcome and death (NCEPOD) survey of acute pancreatitis. Pancreatology. 2018;18:721\u20136.","journal-title":"Pancreatology."},{"key":"2681_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/bjs.6447","volume":"96","author":"MG Besselink","year":"2009","unstructured":"Besselink MG, van Santvoort HC, Boermeester MA, Nieuwenhuijs VB, van Goor H, Dejong CH, et al. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009;96:267\u201373.","journal-title":"Br J Surg"},{"key":"2681_CR24","unstructured":"Wolbrink DRJ, Kolwijck E, Ten Oever J, Horvath KD, Bouwense SAW, Schouten JA. Management of infected pancreatic necrosis in the intensive care unit: a narrative review. Clin Microbiol Infect 2019 Jun 22. pii: S1198-743X(19)30361\u20131 Epub ahead of print."},{"key":"2681_CR25","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s00134-003-1956-z","volume":"29","author":"E Maravi-Poma","year":"2003","unstructured":"Maravi-Poma E, Gener J, Alvarez-Lerma F, Olaechea P, Blanco A, Dominguez-Munoz JE. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin. Intensive Care Med. 2003;29:1974\u201380.","journal-title":"Intensive Care Med"},{"key":"2681_CR26","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1128\/AAC.01758-13","volume":"58","author":"AF Voor In 't Holt","year":"2014","unstructured":"Voor In 't Holt AF, Severin JA, Lesaffre EM, Vos MC. A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:2626\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2681_CR27","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/cc12569","volume":"17","author":"AM Hall","year":"2013","unstructured":"Hall AM, Poole LA, Renton B, Wozniak A, Fisher M, Neal T, et al. Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis. Crit Care. 2013;17(2):R49.","journal-title":"Crit Care"},{"key":"2681_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1440-1746.2008.05712.x","volume":"24","author":"R Kochhar","year":"2009","unstructured":"Kochhar R, Ahammed SK, Chakrabarti A, Ray P, Sinha SK, Dutta U, et al. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis. J Gastroenterol Hepatol. 2009;24:743\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2681_CR29","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/cc9961","volume":"15","author":"P Montravers","year":"2011","unstructured":"Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care. 2011;15(1):R17.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2681-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2681-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2681-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:51:45Z","timestamp":1607043105000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2681-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2681-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"21 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the French Society of Anaesthesiology and Critical Care Medicine Ethics Committee (00010254-2015-017) and the French Personal Data Protection Agency (16\u2013023).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"According to French legislation, this observational study did not require the patients\u2019 informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"393"}}